CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Insulin pump (CSII)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00462371
NCT00462371Phase 4Completed
CompareCT.gov

Open-Label, Randomised Trial Comparing Efficacy of Continuous Subcutaneous Insulin Infusion(CSII) and Multiple Daily Insulin Injections (MDII) in Improving Glycemic Control and Quality of Life in Poorly Regulated Type 1 Diabetic Children.

Erasmus Medical Center·interventional·Posted Apr 19, 2007·Updated Apr 19, 2007

In Brief

A Phase 4 clinical trial evaluating Insulin pump (CSII) for Diabetes Mellitus, Type 1 and Child. Completed, across 1 site.

Detailed Summary

Comparison between insulin pump treatment and multiple daily insulin injections in 38 children with type 1 diabetes4-16 years old. Outcome metabolic control, quality of life, impact of disease and cost effectiveness. We hypothesised that insulin pump treatment would give a better metabolic control and quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1, Child
CountriesNetherlands
CollaboratorsMinistry of Health

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 19, 2007
Enrollment StartJan 1, 2002
Study CompletionFeb 1, 2004
TodayJul 2, 2026
Posted 19.2 years ago

Interventions

Insulin pump (CSII)device